Abdulgani Tatar

Abdulgani Tatar

Auto-generated profile, based on publicly available information

Abdulgani Tatar

ATATÜRK ÜNİVERSİTESİ, TIP FAKÜLTESİ

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Neurochemistry International
Verified
Journal Article
Closed access
Hasan TurkezHasan Turkez
Hasan Turkez
MAMehmet Enes Arslan
Mehmet Enes Arslan
ATAbdulgani Tatar
Abdulgani Tatar
AMAdil Mardinoglu
Adil Mardinoglu

1 August 2017 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
HTHasan Türkez
Hasan Türkez
MAMehmet Enes ARSLAN
Mehmet Enes ARSLAN
ESErdal Sönmez
Erdal Sönmez
ATAbdulgani Tatar
Abdulgani Tatar
MAMetin Açıkyıldız
Metin Açıkyıldız
FGFatime Geyikoğlu
Fatime Geyikoğlu


1 January 2018 in Clinical Dysmorphology
Verified
Journal Article
Closed access
PDF file
HEHaktan Bagis ERDEM
Haktan Bagis ERDEM
ISIbrahim Sahin
Ibrahim Sahin
ATAbdulgani Tatar
Abdulgani Tatar

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CKcigdem yuce kahraman
cigdem yuce kahraman
MEMehmet Ertugrul Egin
Mehmet Ertugrul Egin
ATAbdulgani Tatar
Abdulgani Tatar
Hasan TurkezHasan Turkez
Hasan Turkez
AMAdil Mardinoglu
Adil Mardinoglu
Familial Mediterranean fever (FMF) is the most prevalent autoinflammatory disease. Typical findings are recurrent fever attacks with serositis, skin rash, and synovitis. FMF is caused by mutations in the MEFV gene, encoding pyrin protein. Pyrin functions in innate immunity and triggers inflammation via inflammatory mediators’ production and acts as the primary regulatory component of the inflammasome. On the other hand, various miRNAs play crucial roles in the pathogenesis of different types of cancers and immune‐related and neurodegenerative diseases. However, their association with FMF is still unclear. Therefore, in this study, we assessed the roles of selected thirteen miRNAs associated with immune functions. We recruited genetically diagnosed 28 FMF patients and 28 healthy individuals. The expression profiling of the miRNAs was determined by qRT‐PCR and normalized to SNORD61. Our analysis revealed that miR‐34a‐5p, miR‐142‐3p, miR‐216a‐5p, miR‐340‐5p, miR‐429, and miR‐582‐5p were upregulated, whereas miR‐107, miR‐569, and miR‐1304‐5p were downregulated in the FMF patients. Among them, miR‐107 was found to be the most remarkable in M694V homozygous mutants compared to other homozygous mutants. During clinical follow‐up of the patients with M694V mutation, which is closely related to amyloidosis, evaluation of mir‐107 expression might be crucial and suggestive. Our results showed that miRNAs might serve a function in the pathogenesis of FMF. Further studies may provide novel and effective diagnostic and therapeutic agents that target examined miRNAs. Targeting miRNAs in FMF seems to be promising and may yield a new generation of rational therapeutics and diagnostic or monitoring tools enabling FMF treatment.

8 October 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
OYOmer Yakar
Omer Yakar
ATAbdulgani Tatar
Abdulgani Tatar